Written question asked by Chris Green (Conservative) on Friday, 1 September 2023, in the House of Commons. It was due for an answer on Tuesday, 5 September 2023. It was answered by Will Quince (Conservative) on Friday, 8 September 2023 on behalf of the Department of Health and Social Care.
Gene Therapies
- Question
-
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 July 2023 to Question 192548 on Gene Therapies, how many of the advanced therapeutic medicinal products evaluated by the National Institute for Health and Care Excellence that have been recommended for use were gene therapies appraised through the Single Technology Appraisal pathway.
- Answer
-
As of 5 September 2023, the National Institute for Health and Care Excellence has made positive recommendations on eight out of the nine gene therapy medicinal products it has evaluated using its single technology appraisal process.
Secondary information
- Type
- Written question
- Reference
- 195970
- Session
- 2022-23
- Related items
- Subjects
- National Institute for Health and Care Excellence Gene therapies
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-10-05 19:59:16 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/195970
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/195970
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/195970